Hong Kong
· Delayed Price · Currency is HKD Kindstar Globalgene Technology Company Description
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China.
The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, maternity, neurology, and oncology diseases.
It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases.
Additionally, the company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories.
Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, the People’s Republic of China.
| Country | Cayman Islands |
| Founded | 2003 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,011 |
| CEO | Shiang Huang |
Contact Details
Address: Biolake D2-1 Wuhan China | |
| Phone | 86 40 0736 1666 |
| Website | kindstar.com.cn |
Stock Details
| Ticker Symbol | 9960 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG5262E1044 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shiang Huang M.D. | Founder, Executive Chairman, Chief Executive Officer and Chief Medical Officer |
| Zanbing Tu M.B.A. | Co-Founder, Executive Director and Chief Operating Officer |
| Haijie Chai | Executive Director, Chief Financial Officer and Joint Company Secretary |
| Dr. Fan Jian-Bing | Chief Scientific Officer |
| Mei Yi Lee ACIS, ACS, FCIS, FCS | Joint Company Secretary |